KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Xenon Pharmaceuticals (XENE) Net Margin (2016 - 2025)

Historic Net Margin for Xenon Pharmaceuticals (XENE) over the last 11 years, with Q1 2025 value amounting to 867.29%.

  • Xenon Pharmaceuticals' Net Margin changed N/A to 867.29% in Q1 2025 from the same period last year, while for Sep 2025 it was 4269.19%, marking a year-over-year change of. This contributed to the annual value of 1324.32% for FY2022, which is 9062100.0% down from last year.
  • As of Q1 2025, Xenon Pharmaceuticals' Net Margin stood at 867.29%.
  • In the past 5 years, Xenon Pharmaceuticals' Net Margin registered a high of 220.98% during Q1 2022, and its lowest value of 28143.94% during Q3 2022.
  • For the 3-year period, Xenon Pharmaceuticals' Net Margin averaged around 4672.1%, with its median value being 769.17% (2021).
  • Over the last 5 years, Xenon Pharmaceuticals' Net Margin had its largest YoY gain of 1310400bps in 2022, and its largest YoY loss of -278087600bps in 2022.
  • Over the past 3 years, Xenon Pharmaceuticals' Net Margin (Quarter) stood at 671.05% in 2021, then crashed by -4094bps to 28143.94% in 2022, then soared by 97bps to 867.29% in 2025.
  • Its Net Margin was 867.29% in Q1 2025, compared to 28143.94% in Q3 2022 and 5813.06% in Q2 2022.